A pharmaceutical company is developing a new drug. The volume of data that the company generates has grown exponentially over the past few months. The company's researchers regularly require a subset of the entire dataset to be immediately available with minimal lag. However, the entire dataset does not need to be accessed on a daily basis. All the data currently resides in on-premises storage arrays, and the company wants to reduce ongoing capital expenses. Which storage solution should a solutions architect recommend to meet these requirements?
Select one answer.
Purchase Full Access to view answer options & explanation
The first 456 questions in this bank are completely free. Unlock Full Access on the exam page to view all answer choices, verified answers, explanations, and community discussions for all 1,519 questions.
